These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11564260)

  • 21. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
    Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
    J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-21 enhanced glioma cells resistance to carmustine via decreasing Spry2 expression.
    Wang GB; Liu JH; Hu J; Xue K
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5065-5071. PubMed ID: 29228450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
    Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
    J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiosensitization and inhibition of deoxyribonucleic acid repair in rat glioma cells by long-term treatment with 12-O-tetradecanoylphorbol 13-acetate.
    Zhang W; Hara A; Sakai N; Andoh T; Yamada H; Nozawa Y
    Neurosurgery; 1993 Mar; 32(3):432-7; discussion 437. PubMed ID: 8455768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.
    Saleh M; Wiegmans A; Malone Q; Stylli SS; Kaye AH
    J Natl Cancer Inst; 1999 Mar; 91(5):438-45. PubMed ID: 10070943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Meningeal gliomatosis models as a chemosensitivity assay system].
    Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Nakata Y; Sakamoto Y
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):458-63. PubMed ID: 6584085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excision repair cross-complementing rodent repair deficiency gene 2 expression and chloroethylnitrosourea resistance in human glioma cell lines.
    Chen ZP; McQuillan A; Mohr G; Panasci LC
    Neurosurgery; 1998 May; 42(5):1112-9. PubMed ID: 9588557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of antisense epidermal growth factor receptor RNA on the proliferation of rat C6 glioma cells in vitro and in vivo.
    Pu P; Liu X; Liu A; Cui J; Zhang Y
    J Neurosurg; 2000 Jan; 92(1):132-9. PubMed ID: 10616092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation therapy is potentiated by chemotherapy and hyperthermia in human and canine brain tumor cells in vitro.
    Ebert PS; Salcman M
    Neurosurgery; 1994 Apr; 34(4):657-64. PubMed ID: 8008163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
    Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
    Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemotherapeutic strategy in rat brain tumor cells resistant to ACNU using an in vitro colony formation assay].
    Mineura K; Sasaki J; Fushimi S; Sasajima H; Ishino Y; Kowada M
    No To Shinkei; 1989 Sep; 41(9):927-32. PubMed ID: 2590562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells.
    Zheng LT; Lee S; Yin GN; Mori K; Suk K
    J Neurochem; 2009 Dec; 111(5):1238-51. PubMed ID: 19860839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.
    Wang Y; Ying X; Xu H; Yan H; Li X; Tang H
    Int J Nanomedicine; 2017; 12():1369-1384. PubMed ID: 28260885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of sodium butyrate on glioma cells in vitro and in the rat C6 glioma model.
    Engelhard HH; Duncan HA; Kim S; Criswell PS; Van Eldik L
    Neurosurgery; 2001 Mar; 48(3):616-24; discussion 624-5. PubMed ID: 11270553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
    Yang DI; Chen SD; Yang YT; Ju TC; Xu JM; Hsu CY
    Br J Pharmacol; 2004 Mar; 141(6):988-96. PubMed ID: 14980978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.
    Parsa AT; Chakrabarti I; Hurley PT; Chi JH; Hall JS; Kaiser MG; Bruce JN
    Neurosurgery; 2000 Oct; 47(4):993-9; discussion 999-1000. PubMed ID: 11014444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interstitial quinacrine for elimination of abnormal tissue; therapy of experimental glioma.
    Sotelo J; Guevara P; Reyes S; Arrieta O
    Surgery; 2000 Sep; 128(3):439-46. PubMed ID: 10965316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of carmustine on aminofluorene-DNA adducts formation in rat glial tumor cells.
    Hung CF; Wong KT; Chung JG
    Acta Paediatr Taiwan; 2001; 42(2):81-3. PubMed ID: 11355069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of in vitro and in vivo effect of docosahexaenoic acid on rat C6 glioma.
    Nasrollahzadeh J; Siassi F; Doosti M; Eshraghian MR
    J Exp Ther Oncol; 2009; 8(2):95-103. PubMed ID: 20192116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of radiosensitivity by tamoxifen in C6 glioma cells.
    Zhang W; Yamada H; Sakai N; Niikawa S; Nozawa Y
    Neurosurgery; 1992 Oct; 31(4):725-9; discussion 729-30. PubMed ID: 1407459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.